Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholls

Showing results (491-500 of 7,679) with videos related to

Pageof 768
Sort By:
Aging Cell|February 18, 2004
Mitochondrial membrane potential and agingDavid G Nicholls
Endeavour|December 4, 2003
At the cutting edge of historyE Henry Nicholls
Clinical Pharmacology and Therapeutics|June 15, 2018
CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or BothStephen J Nicholls
The Hospital|May 30, 2018
Non-Panel Men and the "Medical Directory"F L Nicholls
Biochimica Et Biophysica Acta|March 21, 2009
Mitochondrial calcium function and dysfunction in the central nervous systemDavid G Nicholls
Annals of the New York Academy of Sciences|December 17, 2008
Oxidative stress and energy crises in neuronal dysfunctionDavid G Nicholls
Cleveland Clinic Journal of Medicine|October 19, 2007
Exposing the complexity of HDLStephen J Nicholls
Current Opinion in Lipidology|July 14, 2009
Relationship between LDL, HDL, blood pressure and atheroma progression in the coronariesStephen J Nicholls
Current Opinion in Investigational Drugs (London, England : 2000)|August 30, 2008
HDL: still a target for new therapies?Stephen J Nicholls
Journal of Cardiovascular Pharmacology|January 1, 1985
Inhibition of the renin-angiotensin system in the treatment of heart failure: why, when, and whereM G Nicholls
Pageof 768

Showing results (491-500 of 7,679) with videos related to

Sort By:
Pageof 768
Aging Cell|February 18, 2004
Mitochondrial membrane potential and agingDavid G Nicholls
Endeavour|December 4, 2003
At the cutting edge of historyE Henry Nicholls
Clinical Pharmacology and Therapeutics|June 15, 2018
CETP-Inhibition and HDL-Cholesterol: A Story of CV Risk or CV Benefit, or BothStephen J Nicholls
The Hospital|May 30, 2018
Non-Panel Men and the "Medical Directory"F L Nicholls
Biochimica Et Biophysica Acta|March 21, 2009
Mitochondrial calcium function and dysfunction in the central nervous systemDavid G Nicholls
Annals of the New York Academy of Sciences|December 17, 2008
Oxidative stress and energy crises in neuronal dysfunctionDavid G Nicholls
Cleveland Clinic Journal of Medicine|October 19, 2007
Exposing the complexity of HDLStephen J Nicholls
Current Opinion in Lipidology|July 14, 2009
Relationship between LDL, HDL, blood pressure and atheroma progression in the coronariesStephen J Nicholls
Current Opinion in Investigational Drugs (London, England : 2000)|August 30, 2008
HDL: still a target for new therapies?Stephen J Nicholls
Journal of Cardiovascular Pharmacology|January 1, 1985
Inhibition of the renin-angiotensin system in the treatment of heart failure: why, when, and whereM G Nicholls
Pageof 768